Modulation of lipid metabolism by mixtures of protamine and chitooligosaccharide through pancreatic lipase inhibitory activity in a rat model

• Published in: Laboratory animal research Vol. 28; no. 1; pp. 31 - 38
• Main Authors: Kang, N.H., Chungbuk National University, Cheongju, Republic of Korea, Lee, W.K., LG Household and HealthCare Research Institute, Daejeon, Republic of Korea, Yi, B.R., Chungbuk National University, Cheongju, Republic of Korea, Park, M.A., Chungbuk National University, Cheongju, Republic of Korea, Lee, H.R., Chungbuk National University, Cheongju, Republic of Korea, Park, S.K., LG Household and HealthCare Research Institute, Daejeon, Republic of Korea, Hwang, K.A., Chungbuk National University, Cheongju, Republic of Korea, Park, H.K., LG Household and HealthCare Research Institute, Daejeon, Republic of Korea, Choi, K.C., Chungbuk National University, Cheongju, Republic of Korea
• Format: Journal Article
• Language: English
• Published: England 한국실험동물학회 01.03.2012; Korean Association for Laboratory Animal Science
• Subjects: chitooligosaccharide; CHOLESTEROL; COLESTEROL; high fat diet; Original; Protamine; TRIGLICERIDOS; TRIGLYCERIDE; TRIGLYCERIDES; 수의학; triglyceride; chitooligosaccharide; cholesterol; Protamine; high fat diet
• ISSN: 1738-6055; 2233-7660
• DOI: 10.5625/lar.2012.28.1.31

Overweight and obesity are usually related with high fat and calorie intake, and seriously causative of lifestyle-related diseases such as cardiovascular disorders, arteriosclerosis, and colon cancer. In this study, we propose a novel dietary therapy against overweight and obesity using mixtures of protamine and chitooligosaccharide (COS), which are known to interrupt the lipid metabolism in the body. Protamine is a dietary protein originated from salmon reproductive organ, and COS is an oligosaccharide made from chitin or chitosan by chemical or enzymatic hydrolysis. In the enzyme activity analysis in vitro, protamine and COS strongly suppressed the activity of pancreatic lipase, which is the primary enzyme for the digestion and absorption of lipids in the intestine. In in vivo animal test, the mixtures of protamine and COS significantly reduced the serum levels of triglyceride (TG), total cholesterol (T-CHO), and low density lipoprotein-cholesterol (LDLC) and inhibited the accumulation of lipids in liver tissue of Sprague Dawley (SD) rats fed high fat diets. On the other hand, they increased fecal TG and T-CHO contents. From these alterations in lipid metabolism, we verified that protamine and COS mixtures could effectively interrupt the digestion and absorption of dietary lipids in the body by inhibiting pancreatic lipase activity. In addition, protamine and COS mixtures increased the serum level of high density lipoprotein-cholesterol (HDLC), responsible for removing cholesterol from cells and protecting atherosclerosis, and therefore decreased the potential risks of cardiovascular diseases by lowering values of the atherogenic index (AI) and cardiac risk factor (CRF). Taken together, we suggest protamine and COS mixtures as a prominent dietary therapy for the prevention of overweight, obesity, and further cardiovascular diseases related with hyperlipidemia.